Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Biology
|
December 15, 2025
Stromal-derived high-molecular-weight hyaluronan mediates radioresistance in the prostate cancer microenvironment
Ryo Saga, Kenta Iwamori, Yoichiro Hosokawa
Medical Physics
|
September 30, 2025
Equivalent relative biological effectiveness for cell survival and micronuclei formation: insights from a biophysical approach
Yusuke Matsuya, Ryo Saga, Yidi Wang, et al.
Computers in Biology and Medicine
|
May 12, 2026
Prediction of tumor control probability in prostate cancer radiotherapy using a biophysical model incorporating cancer stem cell and hypoxia
Ryo Saga, Kenta Iwamori, Yusuke Matsuya, et al.
Biomedical Reports
|
January 27, 2017
Ascorbic acid does not reduce the anticancer effect of radiotherapy
Yoichiro Hosokawa, Ryo Saga, Satoru Monzen, et al.
Acta Histochemica Et Cytochemica
|
March 18, 2021
Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules <i>In Vitro</i>
Yuki Shiroto, Ryo Saga, Hironori Yoshino, et al.
Oncology Letters
|
January 27, 2017
Anti-tumor and anti-invasion effects of a combination of 4-methylumbelliferone and ionizing radiation in human fibrosarcoma cells
Ryo Saga, Satoru Monzen, Mitsuru Chiba, et al.
Journal of Radiation Research
|
April 30, 2019
Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model
Ryo Saga, Yusuke Matsuya, Rei Takahashi, et al.
Oncology Letters
|
June 13, 2019
Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells
Kosho Murata, Ryo Saga, Satoru Monzen, et al.
Scientific Reports
|
April 16, 2021
4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication
Ryo Saga, Yusuke Matsuya, Rei Takahashi, et al.
Biomedical Reports
|
March 17, 2023
DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells
Kentaro Ohuchi, Ryo Saga, Kazuki Hasegawa, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Biology
|
December 15, 2025
Stromal-derived high-molecular-weight hyaluronan mediates radioresistance in the prostate cancer microenvironment
Ryo Saga, Kenta Iwamori, Yoichiro Hosokawa
Medical Physics
|
September 30, 2025
Equivalent relative biological effectiveness for cell survival and micronuclei formation: insights from a biophysical approach
Yusuke Matsuya, Ryo Saga, Yidi Wang, et al.
Computers in Biology and Medicine
|
May 12, 2026
Prediction of tumor control probability in prostate cancer radiotherapy using a biophysical model incorporating cancer stem cell and hypoxia
Ryo Saga, Kenta Iwamori, Yusuke Matsuya, et al.
Biomedical Reports
|
January 27, 2017
Ascorbic acid does not reduce the anticancer effect of radiotherapy
Yoichiro Hosokawa, Ryo Saga, Satoru Monzen, et al.
Acta Histochemica Et Cytochemica
|
March 18, 2021
Matrix Metalloproteinase-2 Activated by Ultraviolet-B Degrades Human Ciliary Zonules <i>In Vitro</i>
Yuki Shiroto, Ryo Saga, Hironori Yoshino, et al.
Oncology Letters
|
January 27, 2017
Anti-tumor and anti-invasion effects of a combination of 4-methylumbelliferone and ionizing radiation in human fibrosarcoma cells
Ryo Saga, Satoru Monzen, Mitsuru Chiba, et al.
Journal of Radiation Research
|
April 30, 2019
Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem cells, based on a stochastic model
Ryo Saga, Yusuke Matsuya, Rei Takahashi, et al.
Oncology Letters
|
June 13, 2019
Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells
Kosho Murata, Ryo Saga, Satoru Monzen, et al.
Scientific Reports
|
April 16, 2021
4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication
Ryo Saga, Yusuke Matsuya, Rei Takahashi, et al.
Biomedical Reports
|
March 17, 2023
DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells
Kentaro Ohuchi, Ryo Saga, Kazuki Hasegawa, et al.
Page
of 3